NMTB/DAMD 17-97-2-7016- Immunoproteomics Approach to Enhance Prostate Cancer Detection and Management” (PI, CASIANO) ( 6/2009 - 3/2011 )
Goals: To exploit the emerging immunoproteomics technology for the identification of tumor-associated antigens (TAA) targeted by the immune system of PCa patients that when combined in an array format could serve as effective diagnostic and prognostic markers.
|